Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GreenTec-99 is a medical technology company specializing in the sustainable production of Technetium-99m (Tc-99m), the most widely used radioisotope in diagnostic nuclear medicine. Based in Huntsville, Alabama, the company has developed a proprietary, non-uranium-based production system that eliminates the need for Highly Enriched Uranium (HEU), addressing critical global supply chain vulnerabilities and environmental concerns. GreenTec-99's platform includes elution apparatus and generator technologies designed to provide a reliable, decentralized source of medical isotopes for hospitals and radiopharmacies. By streamlining the production of Tc-99m, the company supports essential diagnostic procedures in oncology, cardiology, and other therapeutic areas, ensuring patient access to vital imaging services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GreenTec-99.